• All
• Nov. 28(Thu)
• Nov. 29(Fri)
• Nov. 30(Sat)

• Basic/Translational Symposium
• Big Data Research
• Combined Symposium
• Gender Specific Medicine in Gastroenterology
• In-depth Symposium
• Joint Symposium
• Korean GI Frontier
• Meet the Professor
• Metabolism & Obesity
• Multidisciplinary Session
• Nursing Session
• PG Course
• Presidential & Special Lecture
• Primary Care Session
• Symposium
• Video Session
• Plenary Session
• Topic Forum
• E-poster Oral
• General Meeting
• Editor Session
• Free Paper
• E-poster Exhibition
• Luncheon Symposium
• Breakfast Symposium

In-depth Symposium 01 (KSG)  English 

Nov. 28(Thu)	Unveiling the road to early diagnosis of panceatic cancer	Convention Hall C (4F)
Chair(s)	Dong Ki Lee (Korea), Tooru Shimosegawa (Japan)
08:45-09:10	Genetic evolution from PanIN to pancreatic cancer	Kee-Taek Jang (Korea)
09:10-09:35	Challenge to screen early pancreatic cancer in general population	Keiji Hanada (Japan)
09:35-10:05	Genetic predisposition to pancreatic cancer, results from genome-wide association studies (GWAS)	Laufey Amundadottir (USA)
10:05-10:30	How to diagnose early pancreatic cancer: from Japanese experiences	Tooru Shimosegawa (Japan)

Symposium 01 (KASL1)  Korean 

Nov. 28(Thu) 09:00-10:30	Noticeable research of liver disease in year 2019	Convention Hall A+B (4F)
Chair(s)	Jung-Hwan Yoon (Korea), Kwan Soo Byun (Korea)
09:00-09:22	Viral hepatitis	Hyung Joon Yim (Korea)
09:22-09:44	Alcohol-related and non-alcoholic fatty liver diseases	Yong Kyun Cho (Korea)
09:44-10:06	Liver cirrhosis and complications	Moon Young Kim (Korea)
10:06-10:28	Hepatocellular carcinoma	Ju Hyun Shim (Korea)

PG Course 01 (KSNM)  Korean 

Nov. 28(Thu) 09:00-10:30	A to Z of Functional Dyspepsia	Emerald Hall A (3F)
Chair(s)	Sei Jin Youn (Korea), Oh Young Lee (Korea)
09:00-09:22	Pathophysiology	Chung Hyun Tae (Korea)
09:22-09:44	Assessment	Jong Kyu Park (Korea)
09:44-10:06	Pharmacological therapy	Jung Hwan Oh (Korea)
10:06-10:28	Non-pharmacological therapy	Kyoungwon Jung (Korea)

Plenary Session 01 (KCHUGR-KASID-KSNM)  English 

Nov. 28(Thu) 09:00-10:30	Plenary Session	Emerald Hall B (3F)
Chair(s)	Jae Gyu Kim (Korea), Chang-Hun Yang (Korea), Hyojin Park (Korea)
09:00-09:15	Eradication of Helicobacter Pylori infection Decreases Risk for Dyslipidemia: A Cohort Study	Yewan Park (Korea)
09:15-09:30	Clinical Epidemiology of Esophageal Cancer during Recent 10 years: Nationwide Cohort Study of 6354 Patients with Esophageal Cancer in Korea	Hye-Kyung Jung (Korea)
09:30-09:45	Exogenous Vasoactive Intestinal Peptide Maintains Colon Mucosal Lining in Experimental Colitis Models by Attenuating Colonic Mitochondrial Dysfunction through Scavenging of Superoxide and Hydroxyl Radicals: Implications in Ulcerative Colitis	Arpan Maiti (India)
09:45-10:00	Low skeletal muscle mass is an independent risk factor for advanced colorectal neoplasm: Integrative analysis using three skeletal muscle mass indices	Hyo Jeong Lee (Korea)
10:00-10:15	The effect of bile acid as a major regulator of intestinal microbiotia, Especially on different parts of the mice colon	Mingyu Seok (Korea)
10:15-10:30	Lyon Gastro-esophageal Reflux Disease Consensus Criteria is not correlated with Gastroesophageal Reflux Disease Questionnaire in Korean Patients	Hyungchul Park (Korea)

Big Data Research (KSG)  English 

Nov. 28(Thu) 09:00-10:30	Beyond big data to artificial intelligence(AI) in colon cancer	Diamond Hall (3F)
Chair(s)	Ming-Shiang Wu (Taiwan), Hyun-Soo Kim (Korea)
09:00-09:22	Population-based tailored approach by age and sex dependent cutoffs of FIT	Chang Mo Moon (Korea)
09:22-09:44	Big data driven economical appraisal for colorectal cancer screening program	Ming-Fang Yen (Taiwan)
09:44-10:06	AI image classifier for the prediction of histology and endoscopic resectability	Wai Keung Leung (Hong Kong)
10:06-10:28	Deep learning based treatment decision for T1 cancer; endoscopy vs. surgery	Katsuro Ichimasa (Japan)

Special Lecture (KSGC)  English 

Nov. 28(Thu)	Special Lecture	Grand Ballroom B, C (Main 2F)
Chair(s)	Hyunyong Jeong (Korea)
09:40-10:20	Development of Effective Immune Checkpoint Cancer Therapy	Mien-Chie Hung (Taiwan)

Chung Yong Kim Memorial Lecture (KASL)  Korean 

Nov. 28(Thu)	Presidential Lecture - Chung Yong Kim Memorial Lecture	Convention Hall A+B (4F)
Chair(s)	Kwan Sik Lee (Korea)
11:00-11:30	Alcoholic Liver Disease -Past, Present, and Future	Dong Joon Kim (Korea)

In-depth Symposium 02 (KSG)  English 

Nov. 28(Thu) 11:00-12:30	Current status and perspective for early diagnosis of pancreatic cancer	Convention Hall C (4F)
Chair(s)	Laufey Amundadottir (USA), Yong-Tae Kim (Korea)
11:00-11:25	Protein science; liquid-chromatography-tandem mass spectrometry : Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in biology of Pancreatic ductal adenocarcinoma	Kwang Pyo Kim (Korea)
11:25-11:45	Circulating tumor DNA and cells for pancreatic cancer	Dong-Uk Kim (Korea)
11:45-12:05	Pancreatic cancer specific immunological marker: Paradigm shifting in combating with Pancreatic cancer	Dong Ki Lee (Korea)
12:05-12:30	Exosome in pancreatic cancer surveillance	Takahiro Ochiya (Korea)

PG Course 02 (KSGC)  Korean 

Nov. 28(Thu) 11:00-12:30	Clinical problems overlooked in patients with GI cancer	Emerald Hall A (3F)
Chair(s)	Geun Am Song (Korea), Kwang Ro Joo (Korea)
11:00-11:22	Screening and management for High risk patients	Yun Jeong Lim (Korea)
11:22-11:44	Nutitional support guideline	Min Kyu Jung (Korea)
11:44-12:06	Cancer survivorship supporting program	Ji Soo Park (Korea)
12:06-12:28	Now and future direction of hospice and palliative care	Chung-woo Lee (Korea)

Symposium 02 (KSNM1)  English 

Nov. 28(Thu) 11:00-12:30	Updates in GERD	Emerald Hall B (3F)
Chair(s)	Sung Pyo Hong (Korea), Suck Chei Choi (Korea)
11:00-11:22	Novel new options in the medical management of GERD	Nayoung Kim (Korea)
11:22-11:44	Usefulness of esophageal impedance measurement in diagnosis of GERD	Daniel Sifrim (UK)
11:44-12:06	The Lyon Consensus; how is it differ from previous ones?	Edoardo Savarino (Italy)
12:06-12:28	Current status of endoscopic management in GERD	Yuto Shimamura (Japan)

Multidisciplinary Session 01 (KCHUGR)  Korean 

Nov. 28(Thu) 11:00-12:30	Understanding of Eosinophilic Esophagitis	Diamond Hall (3F)
Chair(s)	Soo-Heon Park (Korea), Jung Mogg Kim (Korea)
11:00-11:22	Eosinophils in gastrointestinal tract	YunJae Jung (Korea)
11:22-11:44	Pathophysiology of food allergy and eosinophilic esophagitis	Young-Min Ye (Korea)
11:44-12:06	Updated diagnostic guideline and pharmacologic treatment	Da Hyun Jung (Korea)
12:06-12:28	Eosinophilic esophagitis in pediatrics and dietary treatment	Kunsong Lee (Korea)

Topic Forum 01 (GI Cancer1)  English 

Nov. 28(Thu) 11:00-12:30		Grand Ballroom A (Main 2F)
Chair(s)	Soo Teik Lee (Korea), Dae Young Cheung (Korea)
11:00-11:10	Current status gastric cancer among mongolian population	Tulgaa Lonjid (Mongolia)
11:10-11:20	Gender-specific Effect of dietary and physical activity on gastric cancer : population-based cohort study	Su Youn Nam (Korea)
11:20-11:30	Predictors of smoking cessation after diagnosis of cancer among gastrointestinal cancer survivors: Nationwide population based study	Youn I Choi (Korea)
11:30-11:40	Metformin decreases stomach cancer risk; comparing with other hypoglycemic agents	Hyeon Seok Lee (Korea)
11:40-11:50	Predictive factors for extragastric recurrence of early gastric cancer after curative resection	Young Min Kim (Korea)
11:50-12:05	Topic forum	Dae Young Cheung (Korea)

Gender Specific Medicine in Gastroenterology (KSG) -01  English 

Nov. 28(Thu)	Clinical application of gender medicine: from research to bedside	Grand Ballroom B, C (Main 2F)
Chair(s)	Etsuko Hashimoto (Japan), Seunja Park (Korea)
11:00-11:15	Is it important to know gender difference for FGID patients?	Hidekazu Suzuki (Japan)
11:15-11:30	Gender difference in gastric cancer	Mei-Jyh Chen (Taiwan)
11:30-11:45	Different approach to treat liver disease by gender difference	Jung Il Lee (Korea)
11:45-11:50	Discussion

Gender Specific Medicine in Gastroenterology (KSG) - 02  English 

Nov. 28(Thu)	Development of career promotion program for women and young doctors	Grand Ballroom B, C (Main 2F)
Chair(s)	Hidekazu Suzuki (Japan), Nayoung Kim (Korea)
12:00-12:05	Japan experience	Etsuko Hashimoto (Japan)
12:05-12:10	Korean experience	Seon Mee Park (Korea)
12:10-12:15	Taiwan experience	Mei-Jyh Chen (Taiwan)
12:15-12:30	Discussion

E-poster Oral 01-1 (PB1)  English 

Nov. 28(Thu)		Flamingo (Main 2F)
Chair(s)	Dae Hwan Kang (Korea), Byoung Kwan Son (Korea)
11:00-11:08	Litholytic agents as an alternative treatment modality in patients with biliary dyspepsia	Young Min Kim (Korea)
11:08-11:16	AGT score as a predictor of common bile duct stone using endoscopic ultrasound (EUS) in patients with intermediate probability criteria according to ASGE guidelines	Muhammad Manzoor Ul Haq (Pakistan)
11:16-11:24	Changes of bacteriobilia and clinical outcome in patients with biliary infection	Jai Hoon Yoon (Korea)
11:24-11:32	Benefits and pitfalls of surgical resection after downstaging concurrent chemoradiation therapy in patients with locally advanced perihilar cholangiocarcinoma	Incheon Kang (Korea)
11:32-11:40	Predictive biomarkers in the gemcitabine plus cisplatin for unresectable or recurrent biliary tract cancer: a single-center, prospective study	Boyoung Lee (Korea)

E-poster Oral 01-2 (PB1)  Korean 

Nov. 28(Thu)		Flamingo (Main 2F)
Chair(s)	Eun Kwang Choi (Korea), Dong Kee Jang (Korea)
11:40-11:48	High PD-L1 expression is associated with response to pembrolizumab in patients with advanced biliary tract cancer	Dong Woo Shin (Korea)
11:48-11:56	Efficacy and safety of Pembrolizumab for gemcitabine/cisplatin-refractory biliary tract cancer: multicenter retrospective study	Sang Hoon Lee (Korea)
11:56-12:04	Survival improvement and prognostic factors in recent management of extrahepatic cholangiocarcinoma	Hyo Jung Kim (Korea)
12:04-12:12	Which is the determining factor for selection of the antimicrobial agent in patient with acute cholangitis, bile or blood?	HyoJin Kwon (Korea)
12:04-12:20	Side-by-Side Simultaneous Insertion of Covered Metal Stent and Plastic Stent for Malignant Biliary Obstruction: A Pilot Study for Efficacy, Patency and Safety	Jae Ok Park (Korea)

E-poster Oral 02-1 (LGI1)  English 

Nov. 28(Thu)		Skylark (Main 2F)
Chair(s)	Byung Ik Jang (Korea), Hyun Jung Lee (Korea)
11:00-11:08	Comparison of conventional and modified endoscopic mucosal resections for the treatment of rectal neuroendocrine tumors	Hee Sung Lee (Korea)
11:08-11:16	Patterns of seroid use in Korean patients with inflammatory bowel disease	Yehyun Park (Korea)
11:16-11:24	Comparison of bowel-cleansing efficacy of spit-dose and same-day dose bowel preparation for afternoon colonoscopy in patients with gastrectomy: a prospective randomized study	Tae-Geun Gweon (Korea)
11:24-11:32	Characterization of Intestinal Microbic and Metabolic Microenvironment Signatures of Inflammatory Bowel Disease	Shengtao Zhu (China)
11:32-11:40	A Multicenter, Open-label, Controlled, Randomized Study Comparing 4g Once Daily with 2g Two Times Daily Prolonged-release Mesalamine for Mild to Moderate active Ulcerative Colitis	Kang-Moon Lee (Korea)

E-poster Oral 02-2 (LGI1)  English 

Nov. 28(Thu)		Skylark (Main 2F)
Chair(s)	Jong Pil Im (Korea), Sang-Bum Kang (Korea)
11:40-11:48	Dipstick proteinuria predicts the development of Crohn's disease: a Nationwide Population-based Study	Seona Park (Korea)
11:48-11:56	Modified Enhanced Recovery after Surgery (mERAS) in colorectal surgery: Outcome of novel experience in colorectal surgery in a limited resource setting in South Asia	Chamila Lakmal (Sri Lanka)
11:56-12:04	Effect of Faecal Microbiota Transplantation on Clearance of Carbapenemase-producing Enterobacteraceae.	Boram CHA (Korea)
12:04-12:12	NUDT15 intermediate metabolizers are associated with longer infliximab durability in pediatric Crohn's disease patients treated by combination treatment with infliximab and azathioprine	Eun Sil Kim (Korea)

E-poster Oral 03-1 (UGI1)  Korean 

Nov. 28(Thu)		White Heron (Main 2F)
Chair(s)	Hyungkil Kim (Korea)
11:00-11:08	OLGA and OLGIM stage for the prediction of metachronous gastric neoplasia after endoscopic resection in Helicobacter pylori negative early gastric cancer patients	Jun Hyuk Kang (Korea)
11:08-11:16	Pre-procedural features for predicting the risk of lymph node metastasis in early gastric cancer	Dong-Jun Kim (Korea)
11:16-11:24	Favorable Long-term Outcomes of Endoscopic Submucosal Dissection for Differentiated-type-Predominant Early Gastric Cancer with Histological Heterogeneity	Tae-Se Kim (Korea)
11:24-11:32	Development of Endoscopic Scoring System to Predict Risk of Intestinal type Gastric Cancer: Preliminary prospective study	Hee Kyong Na (Korea)
11:32-11:40	Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma	Ga Hee Kim (Korea)

E-poster Oral 03-2 (UGI1)  English 

Nov. 28(Thu)		White Heron (Main 2F)
Chair(s)	Byung-Wook Kim (Korea), Chan Gyoo Kim (Korea)
11:40-11:48	Accuracy of Endoscopic Ultrasound (EUS) for superficial esophageal cancer and factors affecting overstaging.	Jinju Choi (Korea)
11:48-11:56	Clinical significance of simulation CT images during definitive chemoradiotherapy in locally advanced esophageal cancer	Jungi Yeom (Korea)
11:56-12:04	Comparison between gastrostomy and self-expandable metal stent for malignant esophageal obstruction, after propensity score matching	Joo Hye Song (Korea)
12:04-12:12	Clinical Outcomes of Mucinous Gastric Carcinomas Compared with Non-mucinous and Signet Ring Cell Carcinomas	Honggeun Ahn (Korea)
12:12-12:20	Mucosal transplantation for the management of stricture after endoscopic submucosal dissection	Saif Ullah (China)

Luncheon Symposium 01 (GILEAD)  English 

Nov. 28(Thu) 12:30-13:30	CHB Patients Today and Tomorrow: Journey toward optimal management for CHB patients	Convention Hall A+B (4F)
Chair(s)	Seung Kew Yoon (Korea)
12:30-12:40	CHB patients tomorrow: What we expect from treatment evolution in the near future?	Seung Kew Yoon (Korea)
12:40-13:10	CHB patients today: What we have to do now for CHB patients?	Tetsuya Hosaka (Japan)
13:10-13:30	Q&A, Discussion

Symposium 03 (KASL2)  Korean 

Nov. 28(Thu) 14:00-15:30	Modulation of gut-liver axis in liver diseases: How far have we come?	Convention Hall A+B (4F)
Chair(s)	Jin Mo Yang (Korea), Kwang Cheol Koh (Korea)
14:00-14:20	Serotonin signals through a gut-liver axis to regulate hepatic steatosis	Hail Kim (Korea)
14:20-14:40	Dysbiosis in patients with liver cirrhosis	Do Seon Song (Korea)
14:40-15:00	Gut microbiome and hepatocarcinogenesis	Su Jong Yu (Korea)
15:00-15:20	Modulation of gut-liver axis in liver diseases: How far have we come?	Ki Tae Suk (Korea)
15:20-15:30	Discussion

In-depth Symposium 03 (KSG)  English 

Nov. 28(Thu) 14:00-15:30	Development of novel targets for pancreatic cancer	Convention Hall C (4F)
Chair(s)	Si Young Song (Korea), Hong-Sik Lee (Korea)
14:00-14:30	Cancer meet Microbiome and Immunology	Hansoo Park (Korea)
14:30-15:00	Tumor microenvironment as a therapeutic target for pancreatic cancer	Volker Ellenrieder (Germany)
15:00-15:30	Drug development with genomic big data and artificial intelligence for pancreatic cancer	Si Young Song (Korea)

PG Course 03 (KASID)  Korean 

Nov. 28(Thu) 14:00-15:30	Update on diagnosis of small bowel disease: lessons from cases	Emerald Hall A (3F)
Chair(s)	Hyun Soo Kim (Korea), Eun Young Kim (Korea)
14:00-14:22	Capsule endoscopic findings of various small intestinal diseases	Hyun Joo Song (Korea)
14:22-14:44	Choice of small intestine imaging study: what and when?	Se Hyung Kim (Korea)
14:44-15:06	Diagnostic approach of suspected small bowel bleeding	Sung Hoon Jung (Korea)
15:06-15:28	Diagnostic approach of small bowel tumor	Seong-Ran Jeon (Korea)

Presidential Lecture (KSNM)  Korean 

Nov. 28(Thu)	Presidential Lecture	Emerald Hall B (3F)
Chair(s)	Young Woo Kang (Korea)
14:00-14:40	Pathogenesis and management of functional dyspepsia	Kwang Jae Lee (Korea)

Special Lecture (KSNM)  English 

Nov. 28(Thu)	Special Lecture	Emerald Hall B (3F)
Chair(s)	Young Woo Kang (Korea), Kwang Jae Lee (Korea)
14:40-15:20	Ineffective esophageal motility: from the Stanford 2018 symposium	Daniel Sifrim (UK)

Presidential Lecture (KCHUGR)  Korean 

Nov. 28(Thu)	Presidential Lecture	Diamond Hall (3F)
Chair(s)	Jong-Jae Park (Korea)
14:00-14:40	Extracellular vesicle in gastrointestinal disease and microbiome in gastric carcinogenesis	Jae Gyu Kim (Korea)

Special Lecture (KCHUGR)  English 

Nov. 28(Thu)	Special Lecture	Diamond Hall (3F)
Chair(s)	Jae Gyu Kim (Korea)
14:40-15:20	Personalized nutrition and gut microbiota	Ming-Shiang Wu (Taiwan)

Topic Forum 02 (GI Cancer2)  English 

Nov. 28(Thu) 14:00-15:30		Grand Ballroom A (Main 2F)
Chair(s)	Ki Baik Hahm (Korea), Jae Jun Park (Korea)
14:00-14:10	Classification of Esophageal Cancer Stadium using Recurrent Neural Network (RNN) Model	Rifaldy Fajar (Indonesia)
14:10-14:20	Quantitative analysis/Tissue Characterization for Malignant Mediastinal /Abdominal Lymph nodes using Endoscopic ultrasound Elastography EUS-EG	Kiran Bajaj (Pakistan)
14:20-14:30	Causal relationship between the loss of slc26a9 and gastric cancer	Dumin Yuan (China)
14:30-14:40	Additive tumor-suppressive effect of niclosamide and metformin in mouse model of colorectal cancer	Yoojeong Seo (Korea)
14:40-14:50	MiR-490-3p targets CDK1 through a phase-separation-depend system and inhibits the proliferation of colon cancer cells	Li Min (China)
14:50-15:05	Topic Forum	Jae Hyun Kim (Korea)

E-poster Oral 04-1(PB2)  English 

Nov. 28(Thu)		Flamingo (Main 2F)
Chair(s)	Jong Jin Hyun (Korea), Dong Wook Lee (Korea)
14:00-14:08	Early Nasogastric tube feeding VS Nil per oral in mild to moderate Acute Pancreatitis	Akhilesh Kasyap (Korea)
14:08-14:16	Analysis of optimal procedure time to prevent post-ERCP pancreatitis using decision tree analysis: a retrospective single center analysis	Chang-Min Cho (Korea)
14:16-14:24	Incidence of pancreatic duct injury in pseudocyst and WON: a systematic review.	Yutthaya Ounklin (Thailand)
14:24-14:32	Prognostic value of the cytokine profile in diseases of the pancreas	Saidrakhim Nodirovich Lukmonov (Uzbekistan)
14:32-14:40	Response of pancreatic ductal adenocarcinoma to gemcitabine using human organotypic slice culture model	Jae Hyuck Chang (Korea)

E-poster Oral 04-2 (PB2)  English 

Nov. 28(Thu)	E-poster Oral (PB2)	Flamingo (Main 2F)
Chair(s)	Hyo Jung Kim (Korea), Jimin Han (Korea)
14:40-14:48	EUS-guided pancreatic ductal adenocarcinoma organoid creation	Khanh Cong Pham (Thailand)
14:48-14:56	Correlation of clinical syndromes of chronic pancreatitis depending on the duration of the disease	Saidrakhim Lukmonov (Uzbekistan)
14:56-15:04	Antibiotics for mild to moderately severe acute pancreatitis with fever	Jin Myung Park (Korea)
15:04-15:12	Pancreatic duct stent without pancreatogram may reduce post-ERCP pancreatitis than pancreatic duct stent with pancreatogram	Jae Hyuck Jun (Korea)

E-poster Oral 05-1 (LGI2)  English 

Nov. 28(Thu)		Skylark (Main 2F)
Chair(s)	Hyungkil Kim (Korea), Chang-Kyun Lee (Korea)
14:00-14:08	Clinical Characteristics of Campylobacter Enterocolitis in Korean adults: A retrospective study in a single center	Minseok Yoo (Korea)
14:08-14:16	TL1A affected epithelial-mesenchymal transition in intestinal mucosal epithelial cells of patients with IBD-related intestinal fibrosis	Wenxiu Jia (China)
14:16-14:24	Clinical significance of patch distribution of residual inflammation in UC patients with clinical remission.	Jongbeom Shin (Korea)
14:24-14:32	Clinical outcomes after discontinuation of anti-tumor necrosis factor- agents in inflammatory bowel disease patients with clinical remission: KASID multicenter study	Joo Hye Song (Korea)

E-poster Oral 05-2 (LGI2)  English 

Nov. 28(Thu)		Skylark (Main 2F)
Chair(s)	Jeong-Seon Ji (Korea), Won Moon (Korea)
14:32-14:40	Red Rice Extract Ameliorates Inflammation in an Ulcerative Colitis Model	Napapan Kangwan (Thailand)
14:40-14:48	Allergic rhinitis induced colonic mucosal immune activation in murine model ; Association between Allergic rhinitis and Irritable bowel syndrome	Sang Hyun Kim (Korea)
14:48-14:56	ACTG2 gene mutation and clinical features in patients with chronic intestinal pseudo-obstruction	Jong Woo Hahn (Korea)

E-poster Oral 06-1 (UGI2)  English 

Nov. 28(Thu)		White Heron (Main 2F)
Chair(s)	Sung Kook Kim (Korea), Gwang Ho Baik (Korea)
14:00-14:08	H.PYLORI PREVALENCE IN MONGOLIA BY USING C14 UREA BREATH TEST	Suvd Tumurbaatar (Mongolia)
14:08-14:16	Correlation of Clinical and Endoscopic Findings in Patients with Helicobacter Pylori Infection using Rapid Urease Test: A 10-year Retrospective Study	Virgilio Jr. Sandico Lo (Philippines)
14:16-14:24	Can DPO-PCR based tailored-therapy increase the eradication rate of Helicobacter pylori?	Youngwoo Kim (Korea)
14:24-14:32	Changes in eradication efficacy of fluoroquinolone-containing triple therapy to Helicobacter pylori in Korea	Nayoung Kim (Korea)

E-poster Oral 06-2 (UGI2)  English 

Nov. 28(Thu)		White Heron (Main 2F)
Chair(s)	Ok-Jae Lee (Korea)
14:32-14:40	Combination therapy with PI3K/mTOR dual inhibitor and chloroquine enhances synergistic apoptotic cell death in EBV-infected gastric cancer cells	Miyoung Kim (Korea)
14:40-14:48	MMP-7 expression predicts a poor prognosis in patients with gastric cancer	Taweesak Tongtawee (Thailand)
14:48-14:56	Deep learning with long short-term memory to predict gastric neoplasm in asymptomatic population after a health check-up	Hong Jin Yoon (Korea)
14:56-15:04	Comparison of intestinal vs diffuse type gastric cancer from the perspective of large-scale signaling network	Jun Hyuk Kang (Korea)

Symposium 04 (KASL3)  Korean 

Nov. 28(Thu) 16:00-17:30	Recent updates in management of liver diseases	Convention Hall A+B (4F)
Chair(s)	Kwang-Hyub Han (Korea), Han Chu Lee (Korea)
16:00-16:20	Clinical development of new HBV therapies	Sang Hoon Ahn (Korea)
16:20-16:40	Management of diabetes and dyslipidemia in patients with nonalcoholic steatohepatitis	Seung-Hyun Ko (Korea)
16:40-17:00	Autoimmune hepatitis in real practice	Kang Mo Kim (Korea)
17:00-17:20	Local ablation therapy of hepatocellular carcinoma	Seung Kak Shin (Korea)
17:20-17:30	Discussion

In-depth Symposium 04 (KSG)  English 

Nov. 28(Thu) 16:00-17:30	New hope for treating pancreatic cancer	Convention Hall C (4F)
Chair(s)	Volker Ellenrieder (Germany), Ho Soon Choi (Korea)
16:00-16:25	Direct targeting oncogenic Ras mutants by IgG-format cytosol-penetrating antibody	Yong-Sung Kim (Korea)
16:25-16:45	Extracelluar vesicles (EVs): exosomes and microvesicles	Yong Song Gho (Korea)
16:45-17:05	Targeting altered metabolism in pancreatic cancer	Soo-Youl Kim (Korea)
17:05-17:25	Establishment of PDAC organoids model using EUS-guided tissue biopsy: a new window into understanding PDAC and drug discovery	Joo Kyung Park (Korea)

PG Course 04 (KCHUGR)  Korean 

Nov. 28(Thu) 16:00-17:30	Recent updates in UGI diseases	Emerald Hall A (3F)
Chair(s)	Sang Young Seol (Korea), Sang Woo Lee (Korea)
16:00-16:22	Recent update in Helicobacter pylori infection	Hye-Kyung Jung (Korea)
16:22-16:44	Recent updates in treatment of drug-induced PUD	Moon Kyung Joo (Korea)
16:44-17:06	Recent updates in diagnosis and treatment of gastric SET	Yonghwan Kwon (Korea)
17:06-17:28	Recent updates in treatment of non-variceal upper gastrointestinal bleeding: Introduction of new Korean guideline	Byung-Wook Kim (Korea)

Multidisciplinary Session 02 (KSNM-KASID-KSCP)  Korean 

Nov. 28(Thu) 16:00-17:30	Colonic pseudo-obstruction: still unknown motor disorder but clinicians should know	Emerald Hall B (3F)
Chair(s)	Kyu Joo Park (Korea), Seung-Jae Myung (Korea)
16:00-16:22	What is colonic pseudo-obstruction?	Kee Wook Jung (Korea)
16:22-16:44	Radiologic diagnosis of colonic pseudo-obstruction	Hye Jin Kim (Korea)
16:44-17:06	Medial approach of colonic pseudo-obstruction	Tae Hee Lee (Korea)
17:06-17:28	Surgical approach of colonic pseudo-obstruction	Seung-Bum Ryoo (Korea)

Free Paper 01-1 (UGI1)  English 

Nov. 28(Thu)		Grand Ballroom A (Main 2F)
Chair(s)	Ki Baik Hahm (Korea), Ki Taek Nam (Korea)
16:00-16:10	Loss of Slc26a9 results in the disorder of gastric stem cell differentiation and acid/base homeostasis, which is a key event to the development of chronic atrophic gastritis	Xue-Mei Liu (China)
16:10-16:20	A Novel LincRNA HERES Epigenetically Regulates CACNA2D3 in Esophageal Squamous Cell Carcinoma	Sang Kil Lee (Korea)
16:20-16:30	Tumor suppressor role of miR-363 in esophageal squamous cell carcinoma	Mingxin Zhang (China)
16:30-16:40	LPA1-mediated lysophosphatidic acid signaling promotes esophageal cancer by activating PI3K/AKT signaling pathway	Si Liu (China)

Free Paper 01-2 (UGI1)  English 

Nov. 28(Thu)		Grand Ballroom A (Main 2F)
Chair(s)	Jeong Seop Moon (Korea), Hwoon-Yong Jung (Korea)
16:40-16:50	Vitamin C solution spray can replace sodium thiosulfate solution spray to completely neutralize iodine staining and substantially relieve the mucosal irritation caused by Lugol chromoendoscopy: a multicenter, randomized, double-blind, parallel trial	Duochen Jin (China)
16:50-17:00	IARC's gastric cancer research programs	Jin Young Park (France)
17:00-17:10	Development of a Deep Learning based endoscopic image analyses to differentiated malignant gastric ulcers from benign lesions	Youn I Choi (Korea)
17:10-17:20	Feasibility of Endoscopic Resection in Gastric Gastrointestinal Stromal Tumor	Yu Ri Kim (Korea)
17:20-17:30	H.PYLORI INFECTION RATE AND GASTRIC MUCOSAL CHANGES DURING ENDOSCOPY	Alimaa Sukhbaatar (Mongolia)